Prostate cancer and benign prostatic hyperplasia are major medical problems in the aging male. Prostate cancer is the second leading form of cancer in males, with approximately 96000 cases diagnosed and 26000 deaths annually in the USA. Although usually not fatal, benign prostatic hyperplasia is the second leading cause of surgery in the USA with over 400000 prostatectomies performed each year.
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Although surgery presently represents the most accepted treatment for benign prostatic hyperplasia, several pharmacological approaches are under evaluation. [2] [3] [4] [5] In this paper, we describe the synthesis and X-ray structure determination of 3β-(p-fluorobenzoyloxy)-4,16-pregnadiene-6,20-dione 6. The preparation of 6 is described in Scheme 1.
X-ray data for crystals of the title compound were collected by graphite-monochromatized Mo Kα radiation at 293 K. No absorption correction was applied.
The crystal is not sufficiently stable to X-ray beams and diffracts poorly. The structure was solved by direct methods and refined by fullmatrix least-squares with anisotropic temperature factors for the non-hydrogen atoms. The hydrogen atoms bonded to the carbon atoms were assigned based on the expected bonding geometry. The hydrogen atoms were refined isotropically in the final least-squares cycles. The software used to prepare material for publication was PARST97. 6 Table 1 summarizes the crystal and experimental data. The molecular structure is shown in Fig. 1 . The bond angles, the final atomic parameters for the hydrogen atoms, the anisotropic thermal parameters for non-hydrogen atoms, and the observed and calculated structure factors may be obtained from the first author.
The molecule consists of three six-membered rings and one five-membered ring, all trans fused. For the puckeringparameters values (φ2, θ2 and Q), 7 the six-membered rings A, B and C occur in a half chair ( 1 H2), distorted chair ( 1 C4) and distorted chair ( 1 C4) conformations, respectively. Ring D occurs in a distorted envelope conformation. The bond lengths and angles are normal. The absolute configuration is inferred from the known stereochemistry of 3β-acetoxypregna-5,16-diene-20-one 1.
Compound 1 is commercially available. The stereochemistry of the title compound is as follows: C8-βH is trans to C9-αH; C8-βH is trans to C14-αH; C9-αH is trans to C10-βCH3; C13-βCH3 is trans to C14-αH. There are three intramolecular C-H···O interactions within <3.4 Å and C-H···O angle >105˚ [C3···O3, C12···O4, C18···O4 2.717(3), 3.168(3), 3.333(4)Å; H3···O3, H12B···O4, H18B···O4, 2.288(2), 2.679(2), 2.786(3)Å; C3-H3···O3, C12-H12B···O4, C18-H18B···O4 105.4(2), 111.7(2), 116.9(2)˚]. In addition, there is only one intermolecular C-H···O interaction <3.4Å: C24···O2 (-x+1, +y+ 1/2, -z+2) 3.191(4)Å. Apart from the C···O intra-and intermolecular contacts, the packing in the crystal is entirely due to van der Waals forces. 
